Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Depreciation & Amortization (CF) (2019 - 2025)

IDEAYA Biosciences' Depreciation & Amortization (CF) history spans 7 years, with the latest figure at $721000.0 for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) rose 26.05% year-over-year to $721000.0; the TTM value through Dec 2025 reached $2.7 million, up 13.11%, while the annual FY2025 figure was $2.7 million, 13.11% up from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $721000.0 at IDEAYA Biosciences, up from $661000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $721000.0 in Q4 2025 and bottomed at $382000.0 in Q1 2021.
  • The 5-year median for Depreciation & Amortization (CF) is $582500.0 (2023), against an average of $569450.0.
  • The largest annual shift saw Depreciation & Amortization (CF) surged 31.75% in 2021 before it fell 9.84% in 2024.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $448000.0 in 2021, then grew by 24.55% to $558000.0 in 2022, then rose by 12.72% to $629000.0 in 2023, then dropped by 9.06% to $572000.0 in 2024, then grew by 26.05% to $721000.0 in 2025.
  • Per Business Quant, the three most recent readings for IDYA's Depreciation & Amortization (CF) are $721000.0 (Q4 2025), $661000.0 (Q3 2025), and $718000.0 (Q2 2025).